The initiation of insulin therapy in T2D can be relatively straightforward, but the need for a timely follow-up to assure an optimal titration is a challenge, not only for subjects with diabetes but also for healthcare professionals and healthcare systems. Here, INS is linked to type 2 diabetes mellitus.